Item 1.01. Entry into a Material Definitive Agreement.
As disclosed in the definitive proxy statement filed by IX Acquisition Corp.
(the "Company") with the Securities and Exchange Commission on March 23, 2023
(the "Proxy Statement"), relating to the extraordinary general meeting of
shareholders (the "Meeting"), IX Acquisition Sponsor LLC (the "Sponsor") agreed
that if the Extension Proposal (as defined below) is approved, it or its
designee will deposit into the trust account established in connection with the
Company's initial public offering (the "Trust Account") as a loan, an amount
equal to the lesser of (x) $160,000 or (y) $0.04 per public share multiplied by
the number of public shares outstanding (the "Contribution"), on each of the
following dates: (i) April 13, 2023; and (ii) one business day following the
public announcement by the Company disclosing that the board of directors of the
Company (the "Board") has determined to extend the Deadline Date (as defined
below) for an additional month in accordance with the Extension (as defined
below). On April 13, 2023, the Sponsor advanced $160,000 to the Company for the
first month of extension.
In connection with the Contribution and advances the Sponsor may make in the
future to the Company for working capital expenses, on April 13, 2023, the
Company issued a convertible promissory note to the Sponsor with a principal
amount up to $1 million (the "Note"). The Note bears no interest and is
repayable in full upon the earlier of (a) the date of the consummation of the
Company's initial business combination, or (b) the date of the Company's
liquidation. If the Company does not consummate an initial business combination
by the Extended Date, the Note will be repaid only from funds held outside of
the trust account or will be forfeited, eliminated or otherwise forgiven. Upon
maturity, the outstanding principal of the Note may be converted into warrants,
at a price of $1.00 per warrant, at the option of the Sponsor. Such warrants
will have terms identical to the warrants issued to the Sponsor in a private
placement that closed simultaneously with the Company's initial public offering.
The Contribution and any drawdowns in connection with the Note are subject to
unanimous written consent of the Board and the consent of the Sponsor.
The foregoing description is qualified in its entirety by reference to the Note,
copy of which is attached as Exhibit 10.1 hereto and is incorporated herein by
reference.
Item 2.03. Creation of a Direct Financial Obligation or an Obligation under an
Off-balance Sheet Arrangement of a Registrant.
The disclosure contained in Item 1.01 of this Current Report on Form 8-K is
incorporated by reference in this Item 2.03.
Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal
Year.
The information included in Item 5.07 is incorporated by reference in this item
to the extent required.
Item 5.07. Submission of Matters to a Vote of Security Holders.
On April 10, 2023, the Company held the Meeting. Holders of 18,016,995 of the
Company's ordinary shares were represented in person or by proxy at the Meeting,
which represents approximately 63% of the ordinary shares issued and outstanding
and entitled to vote as of the record date of March 13, 2023.
At the Meeting, the Company's shareholders approved a proposal to amend the
Company's amended and restated memorandum and articles of association (the
"Articles") to provide the Company with the right to extend the date by which
the Company must consummate its initial business combination (the "Extension"),
from April 12, 2023 to May 12, 2023 (the "Extended Date"), and to allow the
Company, without another shareholder vote, by resolution of the Board, to elect
to further extend the Extended Date in one-month increments up to eleven
additional times, or a total of up to twelve months total, up to April 12, 2024
(the "Extension Proposal"). The Company's shareholders also approved a proposal
(the "Redemption Limitation Amendment Proposal") to amend the Articles to
eliminate (i) the limitation that the Company may not redeem public shares in
an amount that would cause the Company's net tangible assets to be less than
$5,000,001 and (ii) the limitation that the Company shall not consummate a
business combination unless the Company has net tangible assets of at least
$5,000,001 immediately prior to, or upon consummation of, or any greater net
tangible asset or cash requirement that may be contained in the agreement
relating to, such business combination. The Company's shareholders also approved
a proposal (the "Founder Share Amendment Proposal") to provide for the right of
a holder of the Company's Class B ordinary shares, par value $0.0001 per share,
to convert such shares into Class A ordinary shares, par value $0.0001 per
share, on a one-for-one basis at any time and from time to time prior to the
closing of a business combination at the election of the holder. The vote
tabulation for the Extension Proposal, Redemption Limitation Amendment Proposal
and the Founder Share Amendment Proposal is set forth below.
Approval of Proposal 1-Extension Proposal
Votes For Votes Against Abstentions
17,777,136 239,859 0
Approval of Proposal 2-Redemption Limitation Amendment Proposal
Votes For Votes Against Abstentions
17,968,694 48,301 0
Approval of Proposal 3-Founder Share Amendment Proposal
Votes For Votes Against Abstentions
17,776,635 240,360 0
In connection with the vote to approve the Extension Proposal, the holders of
18,336,279 Class A ordinary shares properly exercised their right to redeem
their shares for cash at a redemption price of approximately $10.30 per share,
for an aggregate redemption amount of approximately $189 million. After the
satisfaction of such redemptions, the balance in the Company's trust account
will be approximately $48 million.
Under Cayman Islands law, the amendments to the Articles took effect upon
approval of the Extension Proposal, Founder Share Amendment Proposal and
Redemption Limitation Amendment Proposal. The foregoing description of the
amendments to the Articles is qualified in its entirety by the full text of each
of the Amendments to the Amended and Restated Memorandum and Articles of
Association, which are filed as Exhibit 3.1, Exhibit 3.2 and Exhibit 3.3 hereto
and incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
Exhibit
Number Description
3.1 Certificate of Amendment to the Amended and Restated Memorandum and
Articles of Association of IX Acquisition Corp.
3.2 Certificate of Amendment to the Amended and Restated Memorandum and
Articles of Association of IX Acquisition Corp.
3.3 Certificate of Amendment to the Amended and Restated Memorandum and
Articles of Association of IX Acquisition Corp.
10.1 Convertible Promissory Note, dated April 13, 2023, between IX
Acquisition Corp. and IX Acquisition Sponsor LLC.
104 Cover Page Interactive Data File (embedded within the Inline XBRL
document)
© Edgar Online, source Glimpses